This company has been marked as potentially delisted and may not be actively trading. DFP Healthcare Acquisitions (DFPH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DFPH vs. APLT, ACOG, GLSI, CCLD, IXHL, MOLN, CRDF, NKTX, TVGN, and RCELShould you be buying DFP Healthcare Acquisitions stock or one of its competitors? The main competitors of DFP Healthcare Acquisitions include Applied Therapeutics (APLT), Alpha Cognition (ACOG), Greenwich LifeSciences (GLSI), CareCloud (CCLD), Incannex Healthcare (IXHL), Molecular Partners (MOLN), Cardiff Oncology (CRDF), Nkarta (NKTX), Tevogen Bio (TVGN), and Avita Medical (RCEL). These companies are all part of the "medical" sector. DFP Healthcare Acquisitions vs. Its Competitors Applied Therapeutics Alpha Cognition Greenwich LifeSciences CareCloud Incannex Healthcare Molecular Partners Cardiff Oncology Nkarta Tevogen Bio Avita Medical Applied Therapeutics (NASDAQ:APLT) and DFP Healthcare Acquisitions (NASDAQ:DFPH) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk. Do analysts rate APLT or DFPH? Applied Therapeutics presently has a consensus target price of $4.13, suggesting a potential upside of 258.70%. Given Applied Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Applied Therapeutics is more favorable than DFP Healthcare Acquisitions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Therapeutics 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17DFP Healthcare Acquisitions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is APLT or DFPH more profitable? DFP Healthcare Acquisitions' return on equity of -107.60% beat Applied Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Applied TherapeuticsN/A -354.24% -144.16% DFP Healthcare Acquisitions N/A -107.60%-1.47% Do institutionals & insiders believe in APLT or DFPH? 98.3% of Applied Therapeutics shares are owned by institutional investors. 1.6% of Applied Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has preferable valuation & earnings, APLT or DFPH? DFP Healthcare Acquisitions has lower revenue, but higher earnings than Applied Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApplied Therapeutics$460K360.03-$105.62M-$0.45-2.56DFP Healthcare AcquisitionsN/AN/A-$8.34MN/AN/A Does the media refer more to APLT or DFPH? In the previous week, Applied Therapeutics had 4 more articles in the media than DFP Healthcare Acquisitions. MarketBeat recorded 4 mentions for Applied Therapeutics and 0 mentions for DFP Healthcare Acquisitions. Applied Therapeutics' average media sentiment score of 0.88 beat DFP Healthcare Acquisitions' score of 0.00 indicating that Applied Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Applied Therapeutics Positive DFP Healthcare Acquisitions Neutral Which has more risk and volatility, APLT or DFPH? Applied Therapeutics has a beta of 2.07, suggesting that its share price is 107% more volatile than the S&P 500. Comparatively, DFP Healthcare Acquisitions has a beta of 0.03, suggesting that its share price is 97% less volatile than the S&P 500. SummaryApplied Therapeutics beats DFP Healthcare Acquisitions on 9 of the 12 factors compared between the two stocks. Get DFP Healthcare Acquisitions News Delivered to You Automatically Sign up to receive the latest news and ratings for DFPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DFPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DFPH vs. The Competition Export to ExcelMetricDFP Healthcare AcquisitionsOffices & Clinics Of Medical Doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.53M$33.61M$6.04B$10.50BDividend YieldN/AN/A5.73%4.80%P/E RatioN/AN/A84.3627.24Price / SalesN/A0.60502.46196.48Price / CashN/A54.0337.5761.53Price / Book-1.540.3912.356.74Net Income-$8.34M-$7.06M$3.32B$276.59M DFP Healthcare Acquisitions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DFPHDFP Healthcare AcquisitionsN/A$1.34flatN/AN/A$38.53MN/A0.00147,000APLTApplied Therapeutics3.7411 of 5 stars$1.07flat$4.13+285.5%-87.1%$154.09M$460K-2.3830Analyst ForecastACOGAlpha Cognition2.9573 of 5 stars$7.72+5.0%$20.00+159.1%N/A$153.63M$4.59M-4.83N/AHigh Trading VolumeGLSIGreenwich LifeSciences1.2444 of 5 stars$11.44+1.9%$42.00+267.1%-23.7%$153.07MN/A-8.413Analyst ForecastCCLDCareCloud1.7394 of 5 stars$3.47-3.6%$2.50-28.0%+31.8%$152.36M$111.79M-86.753,650News CoverageGap DownIXHLIncannex Healthcare0.8928 of 5 stars$0.43-1.2%N/A-76.8%$152.16M$86K-0.363Gap DownMOLNMolecular Partners1.4866 of 5 stars$3.89+4.9%$8.00+105.7%-26.7%$149.79M$681K-1.87180News CoverageAnalyst ForecastHigh Trading VolumeCRDFCardiff Oncology2.5418 of 5 stars$2.38+6.3%$10.63+346.4%-13.7%$149.02M$680K-2.7420Positive NewsNKTXNkarta2.3899 of 5 stars$2.09+1.5%$13.60+550.7%-39.3%$146.31MN/A-1.41140Gap DownTVGNTevogen Bio2.8253 of 5 stars$0.72-2.4%$10.00+1,281.4%-35.5%$145.94MN/A-3.813RCELAvita Medical2.3376 of 5 stars$5.51+0.7%$11.60+110.5%-49.4%$145.61M$64.25M-2.80130 Related Companies and Tools Related Companies APLT Competitors ACOG Competitors GLSI Competitors CCLD Competitors IXHL Competitors MOLN Competitors CRDF Competitors NKTX Competitors TVGN Competitors RCEL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DFPH) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DFP Healthcare Acquisitions Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DFP Healthcare Acquisitions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
